X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (31) 31
female (25) 25
male (23) 23
middle aged (20) 20
aged (17) 17
diabetes (15) 15
care and treatment (13) 13
research (13) 13
double-blind method (12) 12
risk factors (12) 12
abridged index medicus (11) 11
cardiovascular diseases (11) 11
endocrinology & metabolism (11) 11
medicine, general & internal (11) 11
prevalence (11) 11
type 1 diabetes (11) 11
adult (10) 10
cardiovascular disease (9) 9
diabetes mellitus, type 2 - drug therapy (9) 9
risk (9) 9
type 2 diabetes (9) 9
drug therapy (8) 8
myocardial infarction (8) 8
cardiovascular diseases - mortality (7) 7
cardiovascular diseases - prevention & control (7) 7
complications and side effects (7) 7
diabetes mellitus (7) 7
diabetes mellitus, type 2 - complications (7) 7
dosage and administration (7) 7
follow-up studies (7) 7
glycosylated hemoglobin (7) 7
heart diseases (7) 7
adolescents (6) 6
analysis (6) 6
cerebral infarction (6) 6
cholesterol (6) 6
cross-sectional studies (6) 6
drug therapy, combination (6) 6
endocrinology, diabetes and metabolism (6) 6
glycemic control (6) 6
health aspects (6) 6
hypoglycemic agents - therapeutic use (6) 6
insulin (6) 6
internal medicine (6) 6
mortality (6) 6
treatment outcome (6) 6
young adult (6) 6
adolescent (5) 5
blood pressure (5) 5
brazil (5) 5
cardiovascular diseases - etiology (5) 5
incidence (5) 5
kaplan-meier estimate (5) 5
medical and health sciences (5) 5
medicin och hälsovetenskap (5) 5
metabolic syndrome (5) 5
patient outcomes (5) 5
patients (5) 5
prevention (5) 5
stroke (5) 5
adults (4) 4
brazil - epidemiology (4) 4
cardiac & cardiovascular systems (4) 4
children (4) 4
clinical trials (4) 4
coronary heart disease (4) 4
diabetes mellitus, type 1 - epidemiology (4) 4
diabetes therapy (4) 4
diabetics (4) 4
diagnosis (4) 4
epidemiology (4) 4
glucose (4) 4
heart attacks (4) 4
heart-disease (4) 4
hypertension (4) 4
hypoglycemic agents - adverse effects (4) 4
insulin resistance (4) 4
life sciences (4) 4
ophthalmology (4) 4
population (4) 4
retrospective studies (4) 4
surveys (4) 4
therapy (4) 4
triglycerides (4) 4
usage (4) 4
acute coronary syndromes (3) 3
age (3) 3
biomarkers (3) 3
blood glucose - analysis (3) 3
blood glucose - metabolism (3) 3
blood sugar (3) 3
cardiovascular diseases - complications (3) 3
cardiovascular diseases - epidemiology (3) 3
cardiovascular risk factors (3) 3
case reports (3) 3
chronic complications (3) 3
complications (3) 3
conjunctiva (3) 3
death (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article